Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
CGEM on Nasdaq
There are no Buy or Sell transactions made by UBS Oncology Impact Fund L.P. since 8/21/2023
Holdings reported by UBS Oncology Impact Fund L.P. for Cullinan Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
7.65M |
$95.3M |
$12.46 |
Sep 16, 2021 |
Direct |
|
|
Transactions reported by UBS Oncology Impact Fund L.P. for Cullinan Therapeutics, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.